These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 8314382

  • 1. Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay.
    Hunter EM, Sutherland LA, Cree IA, Dewar JA, Preece PE, Wood RA, Linder D, Andreotti PE.
    Eur J Surg Oncol; 1993 Jun; 19(3):242-9. PubMed ID: 8314382
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro chemosensitivity in breast cancer using ATP-tumor chemosensitivity assay.
    Qi CJ, Ning YL, Zhu YL, Min HY, Ye H, Qian KQ.
    Arch Pharm Res; 2009 Dec; 32(12):1737-42. PubMed ID: 20162402
    [Abstract] [Full Text] [Related]

  • 4. [Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].
    Tian HM, Shi XY, Fu J, Chao DY, Zhang K, Wu LY, Wang JW, Zhang W.
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):296-8. PubMed ID: 15996325
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements.
    Kurbacher CM, Cree IA.
    Methods Mol Med; 2005 May; 110():101-20. PubMed ID: 15901931
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
    O'Meara AT, Sevin BU.
    Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
    [Abstract] [Full Text] [Related]

  • 9. [Value of the adenosine triphosphate chemosensitivity assay for pre-therapeutic determination of the chemosensitivity of breast cancer cells in cell culture].
    Köchli OR, Sevin BU, Schär G, Haller U.
    Geburtshilfe Frauenheilkd; 1995 Jan; 55(1):7-16. PubMed ID: 7705600
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer.
    Moon YW, Choi SH, Kim YT, Sohn JH, Chang J, Kim SK, Park MS, Chung KY, Lee HJ, Kim JH.
    Cancer; 2007 May 01; 109(9):1829-35. PubMed ID: 17366594
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J.
    Cancer Radiother; 2004 Jun 01; 8(3):155-67. PubMed ID: 15217583
    [Abstract] [Full Text] [Related]

  • 15. Potential use of the adenosine triphosphate cell viability assay in endometrial cancer.
    Tam KF, Ng TY, Tsang PC, Li CF, Ngan HY.
    J Soc Gynecol Investig; 2006 Oct 01; 13(7):518-22. PubMed ID: 16979354
    [Abstract] [Full Text] [Related]

  • 16. A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer.
    Cree IA, Kurbacher CM, Lamont A, Hindley AC, Love S, TCA Ovarian Cancer Trial Group.
    Anticancer Drugs; 2007 Oct 01; 18(9):1093-101. PubMed ID: 17704660
    [Abstract] [Full Text] [Related]

  • 17. Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay.
    Tanino H, Oura S, Hoffman RM, Kubota T, Furukawa T, Arimoto J, Yoshimasu T, Hirai I, Bessho T, Suzuma T, Sakurai T, Naito Y.
    Anticancer Res; 2001 Oct 01; 21(6A):4083-6. PubMed ID: 11911296
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of the cytostatic effect of epirubicin and mitoxantrone on native breast carcinoma cells using the ATP tumor chemosensitivity assay].
    Kurbacher CM, Brenne U, Kurbacher JA, Mallmann P, Krebs D.
    Zentralbl Gynakol; 1996 Oct 01; 118(5):271-8. PubMed ID: 8701623
    [Abstract] [Full Text] [Related]

  • 19. [The evaluation of adenosine triphosphate bioluminescence assay for chemosensitivity testing of ovarian cancer cell line].
    Shi W, Gu M, Liang L.
    Zhonghua Fu Chan Ke Za Zhi; 1996 Feb 01; 31(2):79-82. PubMed ID: 8758798
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.